Neovacs Issued New Broad Patent in China for IFNα Kinoid
Feb 09, 2017 13:00 pm UTC| Business
PARIS, Feb. 09, 2017 -- Neovacs (Alternext Paris:ALNEV), a leader in active immunotherapy for the treatment of autoimmune diseases, today announces that it has been granted a new patent from the Chinese Patent Office...
Alder BioPharmaceuticals to Present at the Leerink Partners 6th Annual Global Healthcare Conference
Feb 09, 2017 13:00 pm UTC| Business
BOTHELL, Wash., Feb. 09, 2017 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will webcast its...
EarthLink Receives 2017 INTERNET TELEPHONY Product of the Year Award
Feb 09, 2017 13:00 pm UTC| Business
ATLANTA, Feb. 09, 2017 -- EarthLink (EarthLink Holdings Corp.) (NASDAQ:ELNK), a leading network services provider dedicated to delivering great customer experiences, today announced that TMC, a global, integrated media...
InterCloud Systems Awarded Over $400K of New Contracts
Feb 09, 2017 12:56 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- InterCloud Systems, Inc. (the "Company" or "InterCloud") (OTCQB:ICLD), a leading provider of cloud networking orchestration and automation solutions and services, today announced that it was...
Halcón Resources Announces $700 Million Offering of Unsecured Notes
Feb 09, 2017 12:54 pm UTC| Business
Houston, Texas, Feb. 09, 2017 -- Halcón Resources Corporation (NYSE:HK) (“Halcón” or the “Company”), today announced that, subject to market conditions, it intends to offer $700 million in aggregate principal amount of...
Feb 09, 2017 12:54 pm UTC| Business
Net income:$62.9 million for 2016; $0.40 per share$18.1 million for Q4 2016; $0.11 per share EBITDA:$194.6 million for 2016;$49.9 million for Q4 2016; $9.5 millionbook gain from the sale of Nave Universe and Nave...
Amarin to Participate in the Leerink Partners 6th Annual Global Healthcare Conference
Feb 09, 2017 12:50 pm UTC| Business
BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 09, 2017 -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health,...